This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Harbin Zhenbao Pharmaceutical Co., Ltd.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Innovations of Hongfei Cheng in Pharmaceutical Development
Introduction
Hongfei Cheng is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as inhibitors for specific receptors.
Latest Patents
One of his key patents is titled "Salt form and crystal form serving as FGFR and VEGFR inhibitor compounds, and preparation method therefor." This invention discloses a salt form and a crystal form that act as FGFR and VEGFR inhibitor compounds, along with a preparation method and their medical uses. This patent highlights his innovative approach to addressing critical medical needs.
Career Highlights
Hongfei Cheng is currently associated with Harbin Zhenbao Pharmaceutical Co., Ltd. His work at this company emphasizes his commitment to advancing pharmaceutical research and development. He has been instrumental in creating new compounds that have the potential to improve treatment options for various medical conditions.
Collaborations
He collaborates with talented individuals in his field, including Zhengxia Chen and Shuhui Chen. These partnerships enhance the research and development process, leading to more effective pharmaceutical solutions.
Conclusion
Hongfei Cheng's contributions to pharmaceutical innovations, particularly through his patent on FGFR and VEGFR inhibitors, demonstrate his expertise and dedication to improving healthcare. His work continues to influence the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile